| Title |
Low Carbohydrate Diets and Type 2 Diabetes: What is the Latest Evidence?
|
|---|---|
| Published in |
Diabetes Therapy, October 2015
|
| DOI | 10.1007/s13300-015-0136-9 |
| Pubmed ID | |
| Authors |
Pamela Dyson |
| Abstract |
Low carbohydrate diets are again in the spotlight and have been identified as particularly appropriate for people with type 2 diabetes. There is confusion amongst both health professionals and people with diabetes about the suitability of these diets. This review aims to provide an overview of the latest evidence and to explore the role of low carbohydrate diets for people with type 2 diabetes. An electronic search of English language articles was performed using MEDLINE (2010-May 2015), EMBASE (2010-May 2015), and the Cochrane Central Register of Controlled Trials (2010-May 2015). Only randomized controlled trials comparing interventions evaluating reduced carbohydrate intake with higher carbohydrate intake in people with diagnosed type 2 diabetes were included. Primary outcomes included weight, glycated hemoglobin, and lipid concentrations. Low carbohydrate diets in people with type 2 diabetes were effective for short-term improvements in glycemic control, weight loss, and cardiovascular risk, but this was not sustained over the longer term. Overall, low carbohydrate diets failed to show superiority over higher carbohydrate intakes for any of the measures evaluated including weight loss, glycemic control, lipid concentrations, blood pressure, and compliance with treatment. Recent studies suggest that low carbohydrate diets appear to be safe and effective over the short term, but show no statistical differences from control diets with higher carbohydrate content and cannot be recommended as the default treatment for people with type 2 diabetes. |
X Demographics
The data shown below were collected from the profiles of 116 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 21 | 18% |
| Australia | 14 | 12% |
| United States | 13 | 11% |
| South Africa | 10 | 9% |
| Spain | 2 | 2% |
| Ireland | 2 | 2% |
| Finland | 2 | 2% |
| New Zealand | 2 | 2% |
| Sweden | 2 | 2% |
| Other | 5 | 4% |
| Unknown | 43 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 71 | 61% |
| Practitioners (doctors, other healthcare professionals) | 30 | 26% |
| Scientists | 13 | 11% |
| Science communicators (journalists, bloggers, editors) | 2 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 261 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Netherlands | 1 | <1% |
| Switzerland | 1 | <1% |
| Unknown | 258 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 54 | 21% |
| Student > Bachelor | 53 | 20% |
| Student > Postgraduate | 18 | 7% |
| Researcher | 15 | 6% |
| Student > Ph. D. Student | 13 | 5% |
| Other | 34 | 13% |
| Unknown | 74 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 58 | 22% |
| Medicine and Dentistry | 47 | 18% |
| Agricultural and Biological Sciences | 24 | 9% |
| Biochemistry, Genetics and Molecular Biology | 22 | 8% |
| Social Sciences | 8 | 3% |
| Other | 21 | 8% |
| Unknown | 81 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 143. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 October 2023.
All research outputs
#293,156
of 25,698,912 outputs
Outputs from Diabetes Therapy
#9
of 1,180 outputs
Outputs of similar age
#3,951
of 290,499 outputs
Outputs of similar age from Diabetes Therapy
#2
of 17 outputs
Altmetric has tracked 25,698,912 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,180 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,499 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.